A detailed history of Fmr LLC transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Fmr LLC holds 3,346,663 shares of TYRA stock, worth $53.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,346,663
Previous 3,977,208 15.85%
Holding current value
$53.9 Million
Previous $65.2 Million 17.96%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$14.45 - $20.22 $9.11 Million - $12.7 Million
-630,545 Reduced 15.85%
3,346,663 $53.5 Million
Q1 2024

May 13, 2024

BUY
$11.61 - $20.0 $14 Million - $24.2 Million
1,208,512 Added 43.65%
3,977,208 $65.2 Million
Q4 2023

Feb 13, 2024

SELL
$11.01 - $14.95 $12.4 Million - $16.9 Million
-1,130,131 Reduced 28.99%
2,768,696 $38.3 Million
Q3 2023

Nov 13, 2023

SELL
$13.15 - $16.08 $2.87 Million - $3.51 Million
-218,042 Reduced 5.3%
3,898,827 $53.7 Million
Q2 2023

Aug 11, 2023

BUY
$11.99 - $17.51 $11.6 Million - $17 Million
968,882 Added 30.78%
4,116,869 $70.1 Million
Q1 2023

May 11, 2023

SELL
$6.85 - $16.22 $5.01 Million - $11.9 Million
-731,136 Reduced 18.85%
3,147,987 $50.6 Million
Q4 2022

Feb 13, 2023

SELL
$5.68 - $8.81 $835,971 - $1.3 Million
-147,178 Reduced 3.66%
3,879,123 $29.5 Million
Q3 2022

Nov 10, 2022

BUY
$6.61 - $12.42 $384,774 - $722,980
58,211 Added 1.47%
4,026,301 $35.4 Million
Q2 2022

Aug 12, 2022

SELL
$5.26 - $11.19 $641,693 - $1.37 Million
-121,995 Reduced 2.98%
3,968,090 $28.4 Million
Q1 2022

May 13, 2022

BUY
$10.03 - $14.09 $6.23 Million - $8.75 Million
621,254 Added 17.91%
4,090,085 $43.8 Million
Q4 2021

Feb 14, 2022

BUY
$12.23 - $31.35 $19.1 Million - $48.9 Million
1,560,172 Added 81.74%
3,468,831 $48.8 Million
Q3 2021

Nov 15, 2021

BUY
$16.91 - $26.0 $32.3 Million - $49.6 Million
1,908,659 New
1,908,659 $33.6 Million

Others Institutions Holding TYRA

About Tyra Biosciences, Inc.


  • Ticker TYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,973,600
  • Market Cap $676M
  • Description
  • Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...
More about TYRA
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.